Susannah Gray - Feb 26, 2023 Form 3 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
Director
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Stock symbol
TBPH
Transactions as of
Feb 26, 2023
Transactions value $
$0
Form type
3
Date filed
2/28/2023, 07:14 PM
Previous filing
Jun 10, 2022
Next filing
May 4, 2023

No securities are beneficially owned.